Close Menu

NEW YORK – Emerald Organic Products and Todos Medical said Tuesday that they have formed a joint venture, Corona Diagnostics, to provide screening assays and diagnostic tests for COVID-19 in the US.

Financial and other terms of the deal were not disclosed.

Emerald Organic, a diversified health sciences company, will contribute financing, US domestic distribution know-how, international trade relationships, and assistance in navigating the US healthcare and regulatory landscape, the firms said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.